Dental Call Tracking: What You Can Record
What dental practices may legally record on tracked calls, how two-party consent states change the rules, why transcripts are PHI, and what may reach an ad
Browse practical guidance on privacy-safe healthcare advertising, analytics, patient acquisition, and marketing compliance.
What dental practices may legally record on tracked calls, how two-party consent states change the rules, why transcripts are PHI, and what may reach an ad
Dental practices can measure patient lifetime value and per-channel ROI using aggregate revenue bands and neutral event names, without sending any treatment
Replying to a dental review can confirm someone is a patient, which is a disclosure. Where the PHI line sits for review responses, review-gating, and reviews
How dental support organizations track conversions across many practice locations, roll them up to group level, and keep patient data out of ad platforms.
How to route Facebook Lead Ads into a patient CRM without a HIPAA problem: what Meta sees, which fields to ask, and how to send conversions back safely.
The FDA sent 55 warning letters to telehealth companies over compounded GLP-1 promotion in 2026. What the agency objected to, and how to review your own ads.
Every major FTC health privacy enforcement action, the statute behind it, the penalty amount, and what each one tells you about advertising with health data.
A working ad copy review process for GLP-1 marketing teams: intake, a four-pass rubric, named sign-off, launch logging, and post-launch monitoring that
How to calculate and read customer acquisition cost at a GLP-1 clinic. Denominators that matter, subscription payback, churn, and cost per started treatment.
What Meta and Google ad reviewers check on a GLP-1 pricing page, from branded drug names and imagery to price disclosure and the tracking that runs on it.
In a GLP-1 quiz funnel the risk sits in the tracking layer, not the questions. Where answers leak, which vendors have no BAA, and how to fix the handoff.
A retargeting audience built from GLP-1 page visitors is itself a health-condition list. How to structure retargeting for a GLP-1 clinic without that
Where GLP-1 subscription billing leaks PHI into ad platforms: checkout, item-level ecommerce parameters, receipt pages, renewals, billing portals, and cancel
Google Ads call reporting works for clinics only if the number-swap tag stays off condition pages, recordings stay out of the ad platform, and call conversions
What a clinic should send through Google Ads Data Manager: click IDs, hashed identifiers, neutral conversion names, a value. Everything else stays on your side
How clinics import offline conversions into Google Ads without sending PHI: click ID capture, hashed identifiers, neutral conversion names, and what never
Google hosts lead form assets, so you cannot filter what Google receives. Which questions are safe to ask, how to deliver leads, and how to send conversions
The 2026 HIPAA civil penalty tiers, the criminal tiers, and every marketing-related enforcement action OCR has resolved, with the dollar figure attached to
Ad policy basics for injectors: brand-name drug rules, scope-of-practice and credential claims, before-and-after imagery, and the tracking layer underneath.
Yes, Acuity Scheduling supports HIPAA compliance on Premium and Powerhouse plans once you enable HIPAA and sign the BAA. The BAA covers Acuity only, not the
Attentive is not HIPAA compliant. Its own content policy prohibits protected health information outright. What that means for clinics running patient SMS
Yes, Birdeye publishes a HIPAA addendum for covered entity customers, so it can be used with PHI. Reviews are public, and that is where the real exposure sits.
Braze signs a HIPAA BAA and runs a dedicated HIPAA cluster, but the agreement is narrowly scoped and bans medical records, diagnoses, and test results outright.
Customer.io will act as a business associate and sign a BAA on request, but its own guidance says keep PHI out of messages. What that means for lifecycle